InvestorsHub Logo
Followers 125
Posts 21169
Boards Moderated 0
Alias Born 06/13/2011

Re: jaspirr post# 238255

Thursday, 01/02/2020 9:18:08 PM

Thursday, January 02, 2020 9:18:08 PM

Post# of 429287
Jas re pt 2. Evidence not previously considered by the PTO

Not sure if you are familiar with how Teva ( I think ) invalidated the Lovaza patent held by GSK .

Even tho the patent had been approved for several yrs , Teva was able to find a situation where Lovaza had been used in outside research ... thus in the public domain ... before the patent was issued . They were able to use this to invalidate that patent although I think the case went to appeal

This is all from memory so please chk actual details

My pt is. ..with the Reduce It trial results heralding a new and very large market .... I expect Dr Reddy to go to extreme lengths to find something to try and crack Amarins wall of patents .... just as Teva did with the Lovaza patent .

The PTO was not aware that Lovaza had been in the public domain UNTIL Teva found evidence of such .

I agree that Dr Reddy has a very high bar to get over ... but I’m not as dismissive of the risk ...as some on this board appear to be .
JMO
Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News